HIGHLIGHTS
- What: The study was approved by the Ethics Committee of Zunyi Medical University (No 2020-1-013), with informed consent obtained from all participants. While the study provides valuable insights into the biology of LGESS, several limitations should be acknowledged. While the authors focused on stromal fibroblasts and their role in tumor progression, other cellular components of the tumor microenvironment, such as immune cells, were not analyzed in depth.
- Who: Jinhwan Kim and colleagues from the University of California, Davis, United States have published the Article: Single-cell RNA-seq reveals FGF12 as a prognostic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.